1-5 of 5
Alexander Röth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up

Clinical Trials & Observations
Alexander Röth, Catherine M. Broome, Wilma Barcellini, Tor Henrik Anderson Tvedt, Yoshitaka Miyakawa, Shirley D’Sa, David Cella, Sylvie Bozzi, Deepthi Jayawardene, Ronnie Yoo, Frank Shafer, Marek Wardęcki, Ilene C. Weitz
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5890–5897.
https://doi.org/10.1182/bloodadvances.2022009318
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia

Catherine M. Broome, Alexander Röth, David J. Kuter, Marie Scully, Roy Smith, Jennifer Wang, Caroline Reuter, William Hobbs, Ahmed Daak
Journal: Blood Advances
Blood Adv (2023) 7 (6): 987–996.
https://doi.org/10.1182/bloodadvances.2021006864
Published: 2023
Includes: Supplemental data
Journal Articles

Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease

Clinical Trials & Observations
Lauren C. Bylsma, Anne Gulbech Ording, Adam Rosenthal, Buket Öztürk, Jon P. Fryzek, Jaime Morales Arias, Alexander Röth, Sigbjørn Berentsen
Journal: Blood Advances
Blood Adv (2019) 3 (20): 2980–2985.
https://doi.org/10.1182/bloodadvances.2019000476
Published: 2019
Includes: Supplemental data
Journal Articles

Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial

Clinical Trials & Observations
Alexander Röth, Martin Bommer, Andreas Hüttmann, Dörte Herich-Terhürne, Nils Kuklik, Jan Rekowski, Veronika Lenz, Hubert Schrezenmeier, Ulrich Dührsen
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2543–2549.
https://doi.org/10.1182/bloodadvances.2018024190
Published: 2018
Journal Articles

Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies

Clinical Trials & Observations
Alexander Röth, Scott T. Rottinghaus, Anita Hill, Eric S. Bachman, Jin Seok Kim, Hubert Schrezenmeier, Louis Terriou, Álvaro Urbano-Ispizua, Richard A. Wells, Jun Ho Jang, Austin G. Kulasekararaj, Jeff Szer, Rasha Aguzzi, Andrew I. Damokosh, Lori Shafner, Jong Wook Lee
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2176–2185.
https://doi.org/10.1182/bloodadvances.2018020644
Published: 2018
Includes: Supplemental data